Additional Information

Description

Ketorolac Tromethamine Injection, available in a 30 mg/mL concentration, is supplied in single-dose vials, each containing 1 mL of the solution. This pharmaceutical product is commonly prescribed for the management of moderate to severe pain, providing relief through its potent analgesic properties. Ketorolac tromethamine is a nonsteroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic effects, primarily exerted through inhibition of prostaglandin synthesis. Its parenteral form ensures rapid onset of action, making it particularly suitable for acute pain situations where prompt relief is necessary.

Each vial of Ketorolac Tromethamine Injection is designed for single use, ensuring optimal sterility and dosage precision. The solution is administered via intravenous or intramuscular routes, depending on the healthcare provider's discretion and the patient's condition. As with all NSAIDs, careful consideration of individual patient factors such as renal function, gastrointestinal integrity, and concomitant medication usage is crucial to minimize risks of adverse effects.

The 30 mg/mL concentration offers flexibility in dosing, allowing healthcare professionals to adjust the amount administered according to the severity of pain and the patient's response. The single-dose presentation enhances convenience and reduces the risk of contamination or medication errors during administration. Patients receiving Ketorolac Tromethamine Injection should be closely monitored for adverse reactions, particularly gastrointestinal bleeding, renal impairment, and allergic reactions.